Artwork for podcast Pathfinders in Biopharma
Biotech SPACs: A new route to going public
Episode 512th March 2021 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:30:22

Share Episode


As more firms and investors look to SPACs as an IPO alternative, will this change the way biotech companies access public markets long-term? Our investment banking team goes inside the SPAC boom to explain what companies need to know before choosing their path to going public.